Last updated: April 25, 2024
Sponsor: Joshua Mann, MPH
Overall Status: Active - Recruiting
Phase
N/A
Condition
Leiomyomas
Treatment
N/AClinical Study ID
NCT03749980
0001
All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patients with von Hippel-Lindau Disease (VHL)
Exclusion
Exclusion Criteria:
Study Design
Total Participants: 10000
Study Start date:
January 01, 2012
Estimated Completion Date:
December 31, 2028
Connect with a study center
VHL Alliance
Boston, Massachusetts 02132
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.